October 4, 2021 Certara Senior Scientific Leader Receives 2021 Leadership Award by International Society of Pharmacometrics
September 30, 2021 Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
September 20, 2021 Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
September 13, 2021 Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares